First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.235 USD 1.09% Market Closed
Updated: May 15, 2024

Aquestive Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Tax Provision
-$241k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Tax Provision
-$3B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Tax Provision
-$289m
CAGR 3-Years
49%
CAGR 5-Years
22%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Tax Provision
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
79%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Tax Provision
-$1.6B
CAGR 3-Years
-14%
CAGR 5-Years
2%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Tax Provision
-$1.4B
CAGR 3-Years
-15%
CAGR 5-Years
-34%
CAGR 10-Years
-4%

See Also

What is Aquestive Therapeutics Inc's Tax Provision?
Tax Provision
-241k USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Tax Provision amounts to -241k USD.